Supported liquid extraction combined with liquid chromatography tandem mass spectrometry for the quantitative analysis of a TLR7 agonist imiquimod LFX453 in plasma at low picograms per milliliter: Method validation and its application to a pharmacokinetic study in minipig
Biomedical Chromatography · 2024
DOI: 10.1002/bmc.5769 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Olivier Heudi und 1 weiteren Autor:innen. Beteiligte Einrichtung: PK Sciences/Bioanalytics, Novartis Pharma AG, Basel, Switzerland. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Toll-Like Receptor 7. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Sample preparation is essential for low‐level compound determination. In the present work, supported liquid extraction (SLE) was used as sample preparation for the low‐level determination of a new TLR7 agonist imiquimod compound, LFX453. Samples were extracted on ISOLUTE® SLE 96‐well plates using tert ‐butyl‐methyl ether followed by evaporation and dry residue reconstitution with 150 μl of a mixture of 0.1% formic acid in acetonitrile–water (50/50, v/v). Samples were eluted using a flow rate of 0.750 ml/min on a C 18 column (50 × 2.1 mm, 2.7 μm) with a mobile phase consisting of 0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B). Tandem mass spectrometry was used to analyze the samples in positive mode. The method run time was 6.5 min, and the low limit of quantification was 1.00 pg/ml with 0.100 ml of minipig plasma. Intra‐run and inter‐run precision and accuracy were within the acceptance criteria at four concentration levels over a concentration ranging from 1.00 to 200 pg/ml. There was no matrix effect and recovery, three freeze–thaw cycles and incurred samples reanalysis were validated. The method was successfully applied for measuring LFX453 in minipig plasma after application on minipig skin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- PK Sciences/Bioanalytics, Novartis Pharma AG, Basel, Switzerland.
ORCID-Profile: Olivier Heudi
Zitieren
APA
Heudi, O., & Winter, S. (2024). Supported liquid extraction combined with liquid chromatography tandem mass spectrometry for the quantitative analysis of a TLR7 agonist imiquimod LFX453 in plasma at low picograms per milliliter: Method validation and its application to a pharmacokinetic study in minipig. Biomedical Chromatography. https://doi.org/10.1002/bmc.5769
Vancouver
Heudi O, Winter S. Supported liquid extraction combined with liquid chromatography tandem mass spectrometry for the quantitative analysis of a TLR7 agonist imiquimod LFX453 in plasma at low picograms per milliliter: Method validation and its application to a pharmacokinetic study in minipig. Biomedical Chromatography. 2024. doi:10.1002/bmc.5769
BibTeX
@article{Heudi2024,
author = {Heudi, Olivier and Winter, Serge},
title = {Supported liquid extraction combined with liquid chromatography tandem mass spectrometry for the quantitative analysis of a TLR7 agonist imiquimod LFX453 in plasma at low picograms per milliliter: Method validation and its application to a pharmacokinetic study in minipig},
journal = {Biomedical Chromatography},
year = {2024},
doi = {10.1002/bmc.5769}
}
EUVIMED